AZN vs NNVC · P/E 28, $288.38B cap vs $22.2M cap
AstraZeneca PLC (AZN) versus NanoViricides Inc (NNVC) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
NanoViricides Inc (NNVC) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported NNVC revenue for 2026-03-31 was $0. Net income was -$6.0M. NNVC currently screens at market cap $22.2M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. NNVC currently screens at market cap $22.2M.
Not investment advice. Open the AZN and NNVC stock pages for the full models.
Not investment advice.